{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Telmisartan+80", "query": { "intervention": "Telmisartan 80" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 24, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Telmisartan+80&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-11T06:23:37.396Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00034840", "title": "Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "telmisartan, valsartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 490, "start_date": "2001-10", "completion_date": "2002-08", "has_results": false, "last_update_posted_date": "2013-11-01", "last_synced_at": "2026-09-11T06:23:37.396Z", "location_count": 16, "location_summary": "Long Beach, California • Los Angeles, California • Orange, California + 12 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Farmington", "state": "Connecticut" }, { "city": "Fort Lauderdale", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00034840" }, { "nct_id": "NCT00168857", "title": "A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension", "Diabetic Nephropathies" ], "interventions": [ { "name": "telmisartan", "type": "DRUG" }, { "name": "losartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "21 Years to 80 Years" }, "enrollment_count": 860, "start_date": "2003-07-09", "completion_date": null, "has_results": false, "last_update_posted_date": "2023-12-08", "last_synced_at": "2026-09-11T06:23:37.396Z", "location_count": 47, "location_summary": "Montgomery, Alabama • Little Rock, Arkansas • Lancaster, California + 41 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Lancaster", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00168857" }, { "nct_id": "NCT00240448", "title": "A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "telmisartan 80 mg/hydrochlorothiazide 25 mg", "type": "DRUG" }, { "name": "valsartan 160 mg/hydrochlorothiazide 25 mg", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1109, "start_date": "2003-09", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-11-05", "last_synced_at": "2026-09-11T06:23:37.396Z", "location_count": 100, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 90 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Sctoosdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00240448" }, { "nct_id": "NCT00281580", "title": "Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Amlodipine 5 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Telmisartan 20 mg", "type": "DRUG" }, { "name": "Telmisartan 40 mg", "type": "DRUG" }, { "name": "Amlodipine 10 mg", "type": "DRUG" }, { "name": "Telmisartan 80 mg", "type": "DRUG" }, { "name": "Amlodipine 2.5 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1461, "start_date": "2006-04", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-03-27", "last_synced_at": "2026-09-11T06:23:37.396Z", "location_count": 101, "location_summary": "Fairhope, Alabama • Huntsville, Alabama • Chandler, Arizona + 81 more", "locations": [ { "city": "Fairhope", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00281580" }, { "nct_id": "NCT00168779", "title": "Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "telmisartan 80 mg / hydrochlorothiazide 25 mg", "type": "DRUG" }, { "name": "valsartan 160 mg / hydrochlorothiazide 25 mg", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1185, "start_date": "2005-09", "completion_date": "2006-07", "has_results": false, "last_update_posted_date": "2017-12-28", "last_synced_at": "2026-09-11T06:23:37.396Z", "location_count": 113, "location_summary": "Athens, Alabama • Birmingham, Alabama • Huntsville, Alabama + 90 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00168779" }, { "nct_id": "NCT02338232", "title": "Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "GVHD" ], "interventions": [ { "name": "Telmisartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hackensack Meridian Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 32, "start_date": "2015-07-07", "completion_date": "2023-01-05", "has_results": true, "last_update_posted_date": "2026-04-02", "last_synced_at": "2026-09-11T06:23:37.396Z", "location_count": 1, "location_summary": "Hackensack, New Jersey", "locations": [ { "city": "Hackensack", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02338232" }, { "nct_id": "NCT01885559", "title": "HALT Progression of Polycystic Kidney Disease Study B", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Kidney, Polycystic" ], "interventions": [ { "name": "Lisinopril", "type": "DRUG" }, { "name": "Telmisartan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "15 Years to 64 Years" }, "enrollment_count": 486, "start_date": "2006-01", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2020-04-22", "last_synced_at": "2026-09-11T06:23:37.396Z", "location_count": 7, "location_summary": "Aurora, Colorado • Atlanta, Georgia • Kansas City, Kansas + 3 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01885559" }, { "nct_id": "NCT00281593", "title": "Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Telmisartan", "type": "DRUG" }, { "name": "Ramipril", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1354, "start_date": "2006-04", "completion_date": null, "has_results": false, "last_update_posted_date": "2017-12-28", "last_synced_at": "2026-09-11T06:23:37.396Z", "location_count": 70, "location_summary": "Glendale, Arizona • Tempe, Arizona • Tucson, Arizona + 58 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Buena Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00281593" }, { "nct_id": "NCT00274638", "title": "PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Telmisartan & Hydrochlorothiazide", "type": "DRUG" }, { "name": "Losartan & Hydrochlorothiazide", "type": "DRUG" }, { "name": "ABPM", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 805, "start_date": "2002-07", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-12-09", "last_synced_at": "2026-09-11T06:23:37.396Z", "location_count": 69, "location_summary": "Huntsville, Alabama • Little Rock, Arkansas • Carmichael, California + 57 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Carmichael", "state": "California" }, { "city": "Concord", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00274638" }, { "nct_id": "NCT02593110", "title": "Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Peripheral Artery Disease" ], "interventions": [ { "name": "Supervised Treadmill Exercise Therapy", "type": "BEHAVIORAL" }, { "name": "Telmisartan", "type": "DRUG" }, { "name": "\"No exercise\" control group", "type": "OTHER" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "DRUG", "OTHER" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 114, "start_date": "2016-01-04", "completion_date": "2022-06-15", "has_results": true, "last_update_posted_date": "2023-01-11", "last_synced_at": "2026-09-11T06:23:37.396Z", "location_count": 3, "location_summary": "Chicago, Illinois • New Orleans, Louisiana", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02593110" } ] }